ACTIVE

Unipharma

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result91,6 k €+4,7 %over 1 year

Gross margin1,1 M €+23,0 %over 1 year

Equity798,9 k €+12,9 %over 1 year

Workforce14,5 ETP+34,3 %over 1 year

Identity

Source · BCE/KBO

Unipharma is a Private limited company incorporated in 1969. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Couvin. It employs on average 14,5 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0406.125.637
Incorporation: 27/01/1969
Legal form: Private limited company
Registered office: Rue de la Ville 6
5660 Couvin · WallonieSee on map
Contributed capital: 74 367,60 €
Latest accounts: 31/12/2025
Average workforce: 14,5 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 69109Legal activities 69109Legal activities 74114Specialised design activities

Joint committees (1)

Signals

ProfitableSolid equityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	1,1 M €	+23.0%	896,9 k €	+16.4%	770,8 k €	-18.0%	940,1 k €	+24.7%	753,6 k €
EBITDA	171,9 k €	+12.1%	153,3 k €	+2510%	5,9 k €	-97.6%	241,7 k €	+63.9%	147,5 k €
Operating result	144,6 k €	+14.6%	126,2 k €	+738%	-19,8 k €	-111%	174,8 k €	+117%	80,6 k €
Net result	91,6 k €	+4.7%	87,4 k €	+359%	-33,7 k €	-127%	123,2 k €	+112%	58,1 k €
Balance sheet
Equity	798,9 k €	+12.9%	707,3 k €	+14.1%	619,8 k €	-14.4%	724,2 k €	+20.5%	601 k €
Total assets	2,5 M €	-1.9%	2,5 M €	+8.1%	2,3 M €	-4.0%	2,4 M €	-2.0%	2,5 M €
Cash	148,1 k €	+29.2%	114,7 k €	+31.7%	87 k €	-49.3%	171,7 k €	-19.8%	213,9 k €
Debts	1,7 M €	-7.7%	1,8 M €	+5.9%	1,7 M €	+0.6%	1,7 M €	-9.3%	1,9 M €
Other
Workforce	14,5 ETP	+34.3%	10,8 ETP	-1.8%	11,0 ETP	+1.9%	10,8 ETP	+5.9%	10,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 9 ended

Active mandates

FRANCOIS MONIN

Director

Active

JEAN CHARLES GAYE

Director

Active

LAURENT STAQUET

Director

Active

Ended mandates

ANNE MARIE COPPE

Director

Ended

ANNE-MARIE COPPE

Director

Ended

BERNARD BAILLEUX

Director

Ended

François MONIN

Chairman of the board of directors

Ended

Other companies at this address

Rue de la Ville 6 5660 Couvin

Company	CBE no.
UREEL PHARMACIE● Active	0810.842.202

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	27/08/2026	28/08/2025	26/08/2024	28/09/2023	19/10/2022	30/08/2021
General meeting	27/08/2026	25/08/2025	27/06/2024	19/09/2023	15/10/2022	22/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	27/08/2026	27/08/2026	French	PDF
Abridged model	31/12/2024	25/08/2025	28/08/2025	French	PDF
Abridged model	31/12/2023	27/06/2024	26/08/2024	French	PDF
Abridged model	31/12/2022	19/09/2023	28/09/2023	French	PDF
Abridged model	31/12/2021	15/10/2022	19/10/2022	French	PDF
Abridged model	31/12/2020	22/06/2021	30/08/2021	French	PDF
Abridged model	31/12/2019	06/10/2020	30/10/2020	French	PDF
Abridged model	31/12/2018	13/06/2019	30/08/2019	French	PDF
Abridged model	31/12/2017	13/06/2018	20/08/2018	French	PDF
Abridged model	31/12/2016	06/06/2017	30/08/2017	French	PDF
Abridged model	31/12/2015	22/06/2016	26/08/2016	French	PDF
Abridged model	31/12/2014	03/06/2015	28/08/2015	French	PDF
Abridged model	31/12/2013	04/06/2014	30/09/2014	French	PDF
Abridged model	31/12/2012	06/06/2013	26/08/2013	French	PDF
Abridged model	31/12/2011	06/06/2012	21/08/2012	French	PDF
Abridged model	31/12/2010	23/05/2011	24/08/2011	French	PDF
Abridged model	31/12/2009	14/06/2010	17/08/2010	French	PDF
Abridged model	31/12/2008	25/05/2009	17/07/2009	French	PDF
Abridged model	31/12/2007	25/06/2008	30/06/2008	French	PDF
Abridged model	31/12/2006	31/05/2007	18/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 9 ended

Active mandates

FRANCOIS MONIN

Director

Active

JEAN CHARLES GAYE

Director

Active

LAURENT STAQUET

Director

Active

Ended mandates

ANNE MARIE COPPE

Director

Ended

ANNE-MARIE COPPE

Director

Ended

BERNARD BAILLEUX

Director

Ended

François MONIN

Chairman of the board of directors

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates19/03/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates22/01/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Mandates23/01/2015
DEMISSIONS, NOMINATIONS - DIVERS
PDF
Mandates07/10/2013
DEMISSIONS, NOMINATIONS
PDF
Mandates07/10/2013
DEMISSIONS, NOMINATIONS
PDF
Mandates10/07/2009
DEMISSIONS, NOMINATIONS
PDF
Registered office04/05/2009
SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL
PDF
Other17/07/2006
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202591,6 k €↑
2024
Annual accounts 202487,4 k €↑
2023
Annual accounts 2023-33,7 k €↓
2022
Annual accounts 2022123,2 k €↑
2021
Annual accounts 202158,1 k €↑
2020
Annual accounts 2020-43,9 k €↑
2019
Annual accounts 2019-49,8 k €↓
2018
Annual accounts 2018-12 k €↓
2017
Annual accounts 20179,4 k €↓
2016
Annual accounts 201634,4 k €↓
2015
Annual accounts 2015125,3 k €↑
2014
Annual accounts 201416,5 k €↓
2013
Annual accounts 2013170,8 k €↑
2012
Annual accounts 2012118,8 k €↑
2011
Annual accounts 2011-12,5 k €↓
2010
Annual accounts 201051,9 k €↓
2009
Annual accounts 2009511,1 k €↑
2008
Annual accounts 2008-403,3 k €↓
2007
Annual accounts 200778,7 k €↑
2006
Annual accounts 2006-107,8 k €
27/01/1969
IncorporationPrivate limited company

Unipharma

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline